Michiel Luteijn

1.2k total citations
24 papers, 779 citations indexed

About

Michiel Luteijn is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Michiel Luteijn has authored 24 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 5 papers in Economics and Econometrics and 4 papers in Infectious Diseases. Recurrent topics in Michiel Luteijn's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Consumer Attitudes and Food Labeling (3 papers) and Pharmaceutical Economics and Policy (3 papers). Michiel Luteijn is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Consumer Attitudes and Food Labeling (3 papers) and Pharmaceutical Economics and Policy (3 papers). Michiel Luteijn collaborates with scholars based in United Kingdom, Netherlands and Norway. Michiel Luteijn's co-authors include Helen Dolk, Matthew A. Brown, Maarten J. Postma, Helga Gunnlaugsdóttir, Hans Verhagen, Øydis Ueland, B.C. White, S.H. Magnússon, Mikko Pohjola and N. Kalogeras and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Human Reproduction.

In The Last Decade

Michiel Luteijn

24 papers receiving 753 citations

Peers

Countries citing papers authored by Michiel Luteijn

Since Specialization

Citations

This map shows the geographic impact of Michiel Luteijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiel Luteijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiel Luteijn more than expected).

Fields of papers citing papers by Michiel Luteijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michiel Luteijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiel Luteijn. The network helps show where Michiel Luteijn may publish in the future.

Co-authorship network of co-authors of Michiel Luteijn

This figure shows the co-authorship network connecting the top 25 collaborators of Michiel Luteijn. A scholar is included among the top collaborators of Michiel Luteijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiel Luteijn. Michiel Luteijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Construction of a demand and capacity model for intensive care and hospital ward beds, and mortality from COVID-19 2021 ·BMC Medical Informatics and Decision Making ·Christopher Martin, (unknown), (unknown), Michiel Luteijn, Rahuldeb Sarkar	7
2	A model framework for projecting the prevalence and impact of Long-COVID in the UK 2021 ·PLoS ONE ·Christopher Martin, Michiel Luteijn, (unknown), (unknown), (unknown)	11
3	Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark 2016 ·PLoS ONE ·Sue Jordan, Joan K. Morris, Gareth Davies, David Tucker, Daniel Thayer, Michiel Luteijn, Margery Morgan, Ester Garne, Anne Vinkel Hansen, Kari Klungsøyr, Anders Engeland, Breidge Boyle, Helen Dolk	50
4	Starting the polypill: the use of a single age cut-off in males and females 2016 ·Journal of Medical Screening ·Nicholas Wald, Michiel Luteijn, Joan K. Morris	4
5	Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke 2016 ·European Journal of Epidemiology ·Nicholas Wald, Michiel Luteijn, Joan K. Morris, David Taylor, Peter Oppenheimer	23
6	The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe 2015 ·Epidemiology ·Michiel Luteijn, Marie‐Claude Addor, Larraitz Arriola, Fabrizio Bianchi, Ester Garne, Babak Khoshnood, Vera Nelen, Amanda J. Neville, Annette Queißer‐Luft, Judith Rankin, Catherine Rounding, Christine Verellen‐Dumoulin, Hermien E. K. de Walle, Diana Wellesley, (unknown), Lyubov Yevtushok, Lolkje de Jong‐van den Berg, Joan K. Morris, Helen Dolk	5
7	Recommendations and Abstracts: The EUROmediCAT Project 2015 ·Pharmacoepidemiology and Drug Safety ·Helen Dolk, Lolkje de Jong‐van den Berg, Anna Pierini, Joan K. Morris, Marian K. Bakker, Sue Jordan, Ester Garne, Kari Klungsøyr, Maria Loane, Rachel Charlton, Michiel Luteijn, Marlene Sinclair, Anna Latos‐Bieleńska	4
8	Influenza and congenital anomalies: a systematic review and meta-analysis 2013 ·Human Reproduction ·Michiel Luteijn, Matthew A. Brown, Helen Dolk	119
9	State of the art in benefit–risk analysis: Economics and Marketing-Finance 2011 ·Food and Chemical Toxicology ·N. Kalogeras, Gaby Odekerken‐Schröder, J.M.E. Pennings, Helga Gunnlaugsdóttir, F. Holm, O. Leino, Michiel Luteijn, S.H. Magnússon, Mikko Pohjola, Mariken Tijhuis, Jouko Tuomisto, Øydis Ueland, B.C. White, Hans Verhagen	17
10	Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus 2011 ·PLoS ONE ·(unknown), Martin Bootsma, Michiel Luteijn, (unknown), David Bishai, Marc J. M. Bonten, Maarten J. Postma	41
11	State of the art in benefit–risk analysis: Food microbiology 2011 ·Food and Chemical Toxicology ·S.H. Magnússon, Helga Gunnlaugsdóttir, Henk Van Loveren, F. Holm, N. Kalogeras, O. Leino, Michiel Luteijn, (unknown), Mikko Pohjola, Mariken Tijhuis, Jouko Tuomisto, Øydis Ueland, B.C. White, Hans Verhagen	30
12	State of the art in benefit–risk analysis: Environmental health 2011 ·Food and Chemical Toxicology ·Mikko Pohjola, O. Leino, Virpi Kollanus, Jouko Tuomisto, Helga Gunnlaugsdóttir, F. Holm, N. Kalogeras, Michiel Luteijn, S.H. Magnússon, (unknown), Mariken Tijhuis, Øydis Ueland, B.C. White, Hans Verhagen	17
13	State of the art in benefit–risk analysis: Introduction 2011 ·Food and Chemical Toxicology ·Hans Verhagen, Mariken Tijhuis, Helga Gunnlaugsdóttir, N. Kalogeras, O. Leino, Michiel Luteijn, S.H. Magnússon, (unknown), Mikko Pohjola, Jouni T. Tuomisto, Øydis Ueland, B.C. White, F. Holm	24
14	Implementation of the Harmonized EU Isotretinoin Pregnancy Prevention Programme 2011 ·Drug Safety ·(unknown), Sabine M. J. M. Straus, Michiel Luteijn, Christine Gispen‐de Wied, June Raine, Lolkje de Jong‐van den Berg	18
15	State of the art in benefit–risk analysis: Food and nutrition 2011 ·Food and Chemical Toxicology ·Mariken Tijhuis, Nynke de Jong, Mikko Pohjola, Helga Gunnlaugsdóttir, Marieke Hendriksen, Jeljer Hoekstra, F. Holm, N. Kalogeras, O. Leino, F.X.R. van Leeuwen, Michiel Luteijn, S.H. Magnússon, (unknown), C.J.M. Rompelberg, Jouni T. Tuomisto, Øydis Ueland, B.C. White, Hans Verhagen	58
16	Differences in pandemic influenza vaccination policies for pregnant women in Europe 2011 ·BMC Public Health ·Michiel Luteijn, Helen Dolk, Gordon Marnoch	17
17	Looking beyond borders: Integrating best practices in benefit–risk analysis into the field of Food and Nutrition 2011 ·Food and Chemical Toxicology ·Mariken Tijhuis, Mikko Pohjola, Helga Gunnlaugsdóttir, N. Kalogeras, O. Leino, Michiel Luteijn, S.H. Magnússon, Gaby Odekerken‐Schröder, (unknown), Jouko Tuomisto, Øydis Ueland, B.C. White, F. Holm, Hans Verhagen	21
18	State of the art in benefit–risk analysis: Medicines 2011 ·Food and Chemical Toxicology ·Michiel Luteijn, B.C. White, Helga Gunnlaugsdóttir, F. Holm, N. Kalogeras, O. Leino, S.H. Magnússon, (unknown), Mikko Pohjola, Mariken Tijhuis, Jouko Tuomisto, Øydis Ueland, Paul A. McCarron, Hans Verhagen	18
19	Costs and Consequences of Additional Chest X-Ray in a Tuberculosis Prevention Program in Botswana 2010 ·American Journal of Respiratory and Critical Care Medicine ·Taraz Samandari, David Bishai, Michiel Luteijn, Barudi Mosimaneotsile, Oaitse I. Motsamai, Maarten J. Postma, (unknown)	26
20	Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis 2010 ·Clinical Microbiology and Infection ·Michiel Luteijn, (unknown), Petros Pechlivanoglou, Marc J. M. Bonten, Maarten J. Postma	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact